Abstract
The use of monoclonal antibodies (mAbs) for cancer therapy is one of the most important strategies for current cancer treatment. The epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases, which regulates cancer cell proliferation, survival, and migration, is a major molecular target for antibody-based therapy. ErbB4/HER4, which contains a ligand-binding extracellular region, is activated by several ligands, including neuregulins (NRGs), heparin-binding EGF-like growth factor, betacellulin and epiregulin. Although there are clinically approved antibodies for ErbB1 and ErbB2, there are no available therapeutic mAbs for ErbB4, and it is not known whether ErbB4 is a useful target for antibody-based cancer therapy. In this study, we developed an anti-ErbB4 mAb (clone P6-1) that suppresses NRG-dependent activation of ErbB4 and examined its effect on breast cancer cell proliferation in the extracellular matrix.
References
Dec 2, 1993·Nature·G D PlowmanS Buckley
Mar 17, 1997·The EMBO Journal·K EleniusM Klagsbrun
May 29, 1997·Nature·K L CarrawayC Lai
Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·D ZhangP J Godowski
Jan 7, 1998·Oncogene·T KomurasakiS Morimoto
May 29, 1999·Oncogene·D HarariY Yarden
Oct 6, 1999·The Journal of Cell Biology·F E JonesD F Stern
May 10, 2001·Trends in Cardiovascular Medicine·T T JunttilaK Elenius
Jun 8, 2001·Molecular and Cellular Biology·C I SartorH S Earp
Jun 12, 2001·Current Opinion in Neurobiology·A Buonanno, G D Fischbach
Mar 22, 2003·Experimental Cell Research·Graham Carpenter
Jun 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hester TidcombeJon P Golding
Jul 16, 2004·Journal of Cellular Physiology·Patrizia CasaliniSylvie Ménard
Mar 1, 2005·Cancer Research·Teemu T JunttilaKlaus Elenius
Aug 17, 2006·Cancer Research·Yun ZhuFrank E Jones
Aug 18, 2006·Molecular and Cellular Biology·Rebecca S Muraoka-CookH Shelton Earp
Mar 31, 2007·Nature Methods·Genee Y LeeMina J Bissell
Jul 20, 2007·Cancer Research·Conor C LynchLynn M Matrisian
Feb 26, 2008·Cancer Science·Yoshiya OhnoTakashi Masuko
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Mar 22, 2014·Cancer Cell·Carlos L Arteaga, Jeffrey A Engelman
Dec 11, 2014·Science Signaling·Jonathan W HaskinsDavid F Stern
Jan 16, 2015·Cell Cycle·Kaleigh CanfieldManabu Kurokawa
Citations
Mar 10, 2018·PLoS Genetics·Ulrika A HänninenLauri A Aaltonen
Apr 22, 2017·The International Journal of Biological Markers·Francesca De IuliisSusanna Scarpa
Jul 31, 2018·Cancer Science·Yuta HaraTakashi Masuko
Feb 13, 2019·Journal of Cellular Biochemistry·Guodong HanHongsheng Li
Mar 18, 2020·Acta Biochimica Et Biophysica Sinica·Xiaodong LiJianhua Lin
May 30, 2019·Oncotarget·Gero Brockhoff
Nov 29, 2017·Oncotarget·Jose Mauricio MotaBenedito A Carneiro
Feb 1, 2020·Oncotarget·Kouki OkitaTakashi Masuko
May 18, 2020·Cancer Science·Romain LanotteThierry Chardès
Jun 18, 2020·Translational Psychiatry·Liang Shi, Clare M Bergson
Mar 29, 2020·Cellular Oncology (Dordrecht)·Vincent F M SegersGilles W De Keulenaer
Oct 26, 2016·The Journal of Biological Chemistry·Casimiro GerarduzziZhi-Min Yuan
Jun 3, 2017·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Sumi YunHye Seung Lee
Jan 5, 2021·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takashi Masuko
Dec 20, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Isabel de LaveraAna P Zaderenko